M&A & Transaction Advisory · Australia ↔ Southeast Asia

Advisory for the companies shaping how the region lives well.

Upsilon Capital Partners is a specialist transaction advisory firm for founder-led wellness, consumer health and healthcare businesses across the Australia–Southeast Asia corridor.

AUD 5–75m
Enterprise value range
AUD 10–40m
Core sweet spot
Sell · Buy · Capital
Mandate types
3 markets
Sydney · Singapore · HCMC
The Firm

We work with a small number of founders and families each year — those who have built something enduring in health and wellness, and who deserve counsel that is specialist, discreet and genuinely aligned when it matters most.

What we do

A complete advisory architecture, from first review to close.

Six connected mandates that take a founder-led business from transaction readiness through to a signed, well-structured deal — and the intelligence that informs every step.

01

Transaction Readiness Review

A candid assessment of value drivers, risks and gaps before you go to market — so the process starts from strength, not surprise.

02

Valuation & Deal Structuring

Defensible valuation and structures that balance price, risk and founder objectives across earn-outs, rollover and staged consideration.

03
Flagship

Sell-side M&A

End-to-end management of the sale: positioning, buyer curation, competitive tension and negotiation — run with discretion and control.

04

Buy-side Advisory

Origination, diligence coordination and negotiation support for acquirers building in the wellness and healthcare space.

05

Capital Advisory

Introductions to aligned growth, minority and structured capital for founders raising without ceding control of the business.

06

UCP Intelligence

Proprietary sector research and a live view of buyers, multiples and momentum across the Australia–Southeast Asia corridor.

Where we focus

Depth in three sectors — not breadth across all of them.

Specialisation is our advantage. We concentrate on the parts of health and wellness where founder-led businesses are being built, and where informed buyers are actively looking.

Sector 01

Consumer Health & Family Wellness

Mother & baby, VMS and supplements, derma-cosmetics — and the distribution that carries them across APAC.

Sector 02

Preventive, Metabolic & Diagnostic

Diagnostics and labs, metabolic clinics, screening and adherence — Asia's largest emerging demand curve.

Sector 03

Healthcare Enablement

The picks-and-shovels: pharma distribution, CDMO / CMO, cold chain and medical device.

How we work

The principles behind every mandate.

I

Specialist, not generalist

We advise only where we have genuine depth. That focus earns sharper judgement, warmer buyer relationships and a stronger case for value.

II

The corridor advantage

Australia as home market, Singapore as capital hub, Vietnam as origination — we connect regional founders with cross-border capital most local advisers cannot reach.

III

Founder-aligned & discreet

We take a deliberately small number of mandates so every process has partner attention and the confidentiality a sale of your life's work demands.

IV

Intelligence-led

Positioning and price are grounded in proprietary data on who is buying, at what multiples, and where momentum is building.

Sydney
Home market
Singapore
Capital hub
Ho Chi Minh City
Origination
UCP Intelligence

The advisory that also publishes the map.

Sector maps, transaction comparables and a monthly brief for founders, investors and advisers across the Australia–Southeast Asia wellness & healthcare corridor. Intelligence is how we originate — and how we stay a step ahead for the clients we act for.

Subscribe to The Brief

Monthly · corridor deal round-up, one chart and a founder's view · unsubscribe anytime.

Open Intelligence

Free · gated
  • The Brief — monthly newsletter, corridor deals and one chart.
  • Sector maps — who owns what across the corridor, refreshed quarterly.
  • Flagship report — our annual founder-succession & M&A study.
Free — a work email is all we ask.

UCP Intelligence Pro

Subscription
  • Transaction comparables — multiples and terms across lower-middle-market health.
  • Buyer & target databases — strategics, funds and founder-succession candidates.
  • Regulatory briefings — ownership and licensing, market by market.
Retainer / subscription — for active buyers and advisers.
UCP Flagship · 2027
The Founder Succession & M&A Report
Australia ↔ Southeast Asia · Wellness & Healthcare
Gated — email to download

Australia's wellness succession wave, quantified.

More than 500,000 Australian businesses are owned by principals aged 60 or over, and 48% of those owners plan to exit within five years. The report sizes the deal supply, benchmarks multiples by sub-sector, and maps the cross-border capital flows moving through the corridor.

Download = subscribe to The Brief. Unsubscribe anytime.
Angelia Le
Managing Partner
M&A · Private Equity · Venture Capital
Leadership

Institutional-grade advisory, brought to the region's founders.

Angelia Le founded Upsilon Capital Partners after more than fifteen years across mergers & acquisitions, private equity and venture capital in the Asia-Pacific — advising and investing alongside founders through some of the most consequential decisions of their businesses.

She built UCP to close a gap she saw first-hand: founder-led wellness and healthcare companies in Southeast Asia deserve the same calibre of transaction counsel as any deal in Sydney or Singapore, delivered with specialist knowledge of their sector and their market.

Angelia Le
Industry Advisors

Sector depth from the people who run it.

Trần Đại Thắng
Senior Advisor, Healthcare Technology (Vietnam)
EHC Group · Lobby.vn

Thắng is Chairman of EHC Group, a Vietnamese healthcare technology company whose hospital information, electronic medical record, laboratory and imaging systems are deployed in more than 50 hospitals in Vietnam and abroad, including national specialist hospitals.

He brings UCP an operator's view of how Vietnamese hospitals buy, implement and pay for technology — the part of a healthcare-enablement deal that financial diligence alone does not see. At UCP he advises on sector themes and diligence in health technology and diagnostics, and contributes to UCP Intelligence. He is also the founder of Lobby.vn, a business-networking platform.

Focus
  • Hospital digitisation
  • Health-tech diligence
  • Diagnostics
  • Vietnam healthcare ecosystem
Begin a conversation

Considering a transaction — or simply the options ahead?

Every mandate begins with a confidential, no-obligation conversation. We are selective about the businesses we take on, and generous with the founders we meet.